Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy.
Saved in:
| Title: | Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy. |
|---|---|
| Authors: | Long, Junyu1 (AUTHOR), Yang, Xu1 (AUTHOR), Bian, Jin1 (AUTHOR), Wang, Dongxu1 (AUTHOR), Wang, Anqiang2 (AUTHOR), Lin, Yu3 (AUTHOR), Zheng, Mingjun4 (AUTHOR), Zhang, Haohai5 (AUTHOR), Sang, Xinting1 (AUTHOR) sangxt@pumch.cn, Zhao, Haitao1 (AUTHOR) ZhaoHT@pumch.cn |
| Source: | Clinical & Translational Medicine. Nov2021, Vol. 11 Issue 11, p1-5. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20011326 |
|---|---|
| DOI: | 10.1002/ctm2.598 |
